These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25701862)

  • 21. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Lynn RC; Wagner-Mann CC; Michels GM
    J Am Vet Med Assoc; 2001 Jan; 218(1):38-42. PubMed ID: 11149712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Perry CM
    Drugs; 2004; 64(22):2577-95. PubMed ID: 15516157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study.
    Damci T; Emral R; Svendsen AL; Balkir T; Vora J;
    BMC Endocr Disord; 2014 Jul; 14():61. PubMed ID: 25048824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995).
    Goossens MM; Nelson RW; Feldman EC; Griffey SM
    J Vet Intern Med; 1998; 12(1):1-6. PubMed ID: 9503353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treat-to-target trials: uses, interpretation and review of concepts.
    Garber AJ
    Diabetes Obes Metab; 2014 Mar; 16(3):193-205. PubMed ID: 23668598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".
    Ghosal S; Sinha B; Majumder A; Das AK; Singh AK; Ghoshdastidar B; Maji D; Goyal G; Mukherjee JJ; Gangopadhyay KK; John M; Chatterjee S; Jaggi S; Ray S; Majumdar S; Sharma SK
    J Assoc Physicians India; 2017 Jul; 65(7):51-62. PubMed ID: 28792170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE.
    Dornhorst A; Lüddeke HJ; Koenen C; Meriläinen M; King A; Robinson A; Sreenan S;
    Diabetes Obes Metab; 2008 Jan; 10(1):75-81. PubMed ID: 18034846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study.
    Meneghini LF; Rosenberg KH; Koenen C; Merilainen MJ; Lüddeke HJ
    Diabetes Obes Metab; 2007 May; 9(3):418-27. PubMed ID: 17391170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin Therapy in Small Animals, Part 1: General Principles.
    Fleeman L; Gilor C
    Vet Clin North Am Small Anim Pract; 2023 May; 53(3):615-633. PubMed ID: 36906469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ISFM and AAFP consensus guidelines: long-term use of NSAIDs in cats.
    Sparkes AH; Heiene R; Lascelles BD; Malik R; Sampietro LR; Robertson S; Scherk M; Taylor P;
    J Feline Med Surg; 2010 Jul; 12(7):521-38. PubMed ID: 20610311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptance of home blood glucose monitoring by owners of recently diagnosed diabetic cats and impact on quality of life changes in cat and owner.
    Hazuchova K; Gostelow R; Scudder C; Forcada Y; Church DB; Niessen SJ
    J Feline Med Surg; 2018 Aug; 20(8):711-720. PubMed ID: 28911254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical benefits of switching to insulin degludec irrespective of previous basal insulin therapy in people with Type 1 or Type 2 diabetes: evidence from a European, multicentre, retrospective, non-interventional study (EU-TREAT).
    Knudsen ST; Lapolla A; Schultes B; Tentolouris N; Catarig AM; Wolden ML; Siegmund T
    Diabet Med; 2019 Jul; 36(7):868-877. PubMed ID: 31001865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary study of protamine zinc recombinant insulin for the treatment of diabetes mellitus in cats.
    Norsworthy G; Lynn R; Cole C
    Vet Ther; 2009; 10(1-2):24-8. PubMed ID: 19742445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Insulin Degludec on glycemic control in diabetic cats over a 12-month period.
    Oda H; Mori A; Sako T
    J Vet Med Sci; 2020 Jun; 82(6):695-698. PubMed ID: 32307342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin detemir versus insulin glargine for type 2 diabetes mellitus.
    Swinnen SG; Simon AC; Holleman F; Hoekstra JB; Devries JH
    Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD006383. PubMed ID: 21735405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glargine insulin and high-protein-low-carbohydrate diet in cats with diabetes mellitus.
    Boari A; Aste G; Rocconi F; Dalessandri A; Vita S
    Vet Res Commun; 2008 Sep; 32 Suppl 1():S243-5. PubMed ID: 18685984
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of 46 cats with porcine lente insulin--a prospective, multicentre study.
    Michiels L; Reusch CE; Boari A; Petrie G; Mandigers P; Thollot IG; Rosenberg D; Mooney C; Bonfanti U; Font A; Sparkes A; Bewig K; Clercx C; Jensen AL; Horspool LJ
    J Feline Med Surg; 2008 Oct; 10(5):439-51. PubMed ID: 18619886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.
    Rosenstock J; Davies M; Home PD; Larsen J; Koenen C; Schernthaner G
    Diabetologia; 2008 Mar; 51(3):408-16. PubMed ID: 18204830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.